Literature DB >> 15790316

The diagnosis and management of Kawasaki disease.

J Royle1, D Burgner, N Curtis.   

Abstract

Kawasaki disease (KD) is a systemic vasculitis of childhood with a predilection for the coronary arteries. It is the predominant cause of paediatric acquired heart disease in developed countries. The aetiology of KD remains unknown and consequently there is no diagnostic test. The diagnosis is made using a constellation of clinical criteria that in isolation have poor sensitivity and specificity. Early treatment prevents overt coronary artery damage in the majority of children. The long-term effects of childhood KD on later cardiovascular health remain unknown. A recent study showed that treatment of KD in Australia is suboptimal, with late diagnosis occurring in approximately half of the cases and an unacceptably high incidence of acute cardiac involvement. These guidelines highlight the difficulties in the diagnosis of KD and offer some clues that may assist early recognition of this important paediatric disease. They also detail current treatment recommendations and the evidence on which they are based. Increased awareness of the epidemiology and spectrum of the clinical presentation of KD is essential for early recognition and optimal management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790316     DOI: 10.1111/j.1440-1754.2005.00555.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  9 in total

Review 1.  Diagnostic approach to patients with suspected vasculitis.

Authors:  E Suresh
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

2.  Epidemiologic survey of Kawasaki disease in Inner Mongolia, China, between 2001 and 2013.

Authors:  Xiaomei Zhang; Yanyan Liang; Wanyu Feng; Xuewen Su; Hua Zhu
Journal:  Exp Ther Med       Date:  2016-05-26       Impact factor: 2.447

3.  An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study.

Authors:  Sinan Mahir Kayiran; Aygün Dindar; Berkan Gurakan
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

4.  Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19.

Authors:  Michal Pruc; Jacek Smereka; Tomasz Dzieciatkowski; Milosz Jaguszewski; Krzysztof J Filipiak; Lukasz Szarpak
Journal:  Med Hypotheses       Date:  2020-06-11       Impact factor: 1.538

Review 5.  Kawasaki disease: what is the epidemiology telling us about the etiology?

Authors:  David Burgner; Anthony Harnden
Journal:  Int J Infect Dis       Date:  2005-07       Impact factor: 3.623

Review 6.  Clinical manifestations of mannan-binding lectin deficiency.

Authors:  S Thiel; P D Frederiksen; J C Jensenius
Journal:  Mol Immunol       Date:  2006-01       Impact factor: 4.407

7.  Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease.

Authors:  Hyo Min Park; Dong Won Lee; Myung Chul Hyun; Sang Bum Lee
Journal:  Korean J Pediatr       Date:  2013-02-25

8.  Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities.

Authors:  Hyun Jung Kim; Hyo Eun Lee; Jae Won Yu; Hong Ryang Kil
Journal:  Korean J Pediatr       Date:  2016-08-24

9.  Cytomegalovirus infection in a patient with atypical Kawasaki disease.

Authors:  Belgin Usta Guc; Nurcan Cengiz; Selman Vefa Yildirim; Yasemin Uslu
Journal:  Rheumatol Int       Date:  2007-08-24       Impact factor: 2.631

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.